Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2005
06/14/2005US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005CA2359080C Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester
06/14/2005CA2333703C Isothiazole derivatives useful as anticancer agents
06/09/2005WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/09/2005US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
06/09/2005US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms
06/09/2005US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt
06/09/2005US20050124649 Deazapurines and uses thereof
06/09/2005US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands
06/09/2005US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease
06/09/2005US20050124624 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124617 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
06/09/2005US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
06/09/2005US20050124004 Histamine receptor h3 polynucleotides
06/09/2005US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders
06/09/2005US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches
06/09/2005US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage
06/09/2005US20050123558 Modifeid polypeptide
06/09/2005US20050123543 With an integrin linked kinase (ILK) inhibitor which can be a peptide, an antibody, an antisense agent; optionally also treating with an ACE inhibitor; ACE (Angiotensin Converting Enzyme)
06/09/2005US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis
06/09/2005CA2547235A1 T-type calcium channel blocker
06/08/2005EP1538202A2 Production of human alpha-galactosidase A
06/08/2005EP1537866A1 Drug for kidney failure containing oxaluric acid derivative
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536780A1 Oral liquid tolterodine composition
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1414937B1 Hops extracts, method for the production and use
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625412A Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
06/08/2005CN1625402A Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-D)-pyrimidine for treating of urinary incontinence
06/08/2005CN1625390A Multi-stage oral drug controlled-release system
06/08/2005CN1625346A Powder of amino acids and method for producing the same
06/08/2005CN1624126A Ret ligand (retl) for stimulating neural and renal growth
06/08/2005CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/08/2005CN1205207C Substituted indolealkanoic acids
06/08/2005CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals
06/08/2005CN1205182C Suplates tosilate crystals
06/08/2005CN1204900C Chinese patent drug for treating prostate proliferation and hypertrophy
06/08/2005CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous
06/07/2005US6903186 Analogues of GLP-1
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
06/07/2005US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903091 Kidney diseases; hypotensive agents; blood disorders
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
06/07/2005US6902731 Transcription factors; for arterial administration via stent
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/02/2005WO2004112832A3 Immunogenic compositions comprising multiple gonococcal antigens
06/02/2005US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor
06/02/2005US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release
06/02/2005US20050119291 Pyrimidine compounds
06/02/2005US20050119277 Benzazole derivatives for the treatment of scleroderma
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119165 Vascular endothelial growth factor dimers
06/02/2005US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/02/2005US20050118232 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
06/02/2005CA2545802A1 Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
06/02/2005CA2545641A1 Use of organic compounds
06/01/2005EP1535922A1 Pyrrolopyridine derivative and use thereof
06/01/2005EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
06/01/2005EP1535915A1 Furan or thiophene derivative and medicinal use thereof
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535907A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535623A1 Renal cell carcinoma treatment
06/01/2005EP1535620A1 The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention
06/01/2005EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF
06/01/2005EP1534807A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
06/01/2005EP1534728A2 Antisense modulation of glucocorticoid receptor expression
06/01/2005EP1534725A2 Compounds and methods for inhibiting selectin-mediated function
06/01/2005EP1534715A1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
06/01/2005EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 562